Nephrocare Health Services
Nephrocare Health Services Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Nephrocare Health Services Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Nephrocare Health Services Ltd trades at a P/E of 69.60×.
Valuation
Profitability
Growth
Financial Health
Nephrocare Health Services Ltd financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Nephrocare Health Services Ltd, switchable between annual and quarterly views, consolidated or standalone.
Nephrocare Health Services Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹7,450.3 Cr and reported EPS of ₹322.00.
| Period | 2026 |
|---|---|
| Revenue from Operations | 999 |
| Other Income | 25 |
| Total Income | 1,023 |
| Cost of Goods Sold (COGS) | 227 |
| Gross Profit | 772 |
| +Operating Expenses | 545 |
| EBITDA | 227 |
| +Non-Operating Expenses | 151 |
| Profit Before Tax (PBT) | 101 |
| +Tax Expense | 21 |
| Profit After Tax (PAT) | 77 |
| Earnings Per Share (EPS) | 7.66 |
| Diluted Shares Outstanding (Nos.) | 10 |
| +Additional Disclosures | 1,165 |
| Material Cost % | 23 |
| Employee Cost % | 17 |
| Other Cost % | 37 |
| OPM % | 23 |
| Tax % | 21 |
| Gross Margin % | 0.00 |
| EBITDA Margin % | 0.00 |
| Interest Coverage Ratio | 0.00 |
| Additional Fields | 136 |
Nephrocare Health Services segment analysis: revenue and profit mix.
Disclosed business segments at Nephrocare Health Services with their share of revenue and profit, switchable between consolidated and standalone reporting.
Nephrocare Health Services discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
Nephrocare Health Services Ltd investment thesis: bull case, bear case, and the flip lines.
Why someone would buy Nephrocare Health Services Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
What you're getting.
No strengths or opportunities on record.
What can break it.
No weaknesses or threats on record.
What would change my mind.
Trim if P/E re-rates above 90. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Nephrocare Health Services Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Nephrocare Health Services Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
Nephrocare Health Services Ltd technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Nephrocare Health Services Ltd — derived from the live tape, not yesterday's close.
Nephrocare Health Services Ltd last traded at ₹748.15 with an intraday range of ₹735–₹769.75 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹748.15| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 836.43 | +88.28 | +11.80% |
| R3 | 801.68 | +53.53 | +7.16% |
| R2 | 785.72 | +37.57 | +5.02% |
| R1 | 766.93 | +18.78 | +2.51% |
| PIVOT | 750.97 | 2.82 | 0.38% |
| CURRENT | 748.15 | — | — |
| S1 | 662.68 | -85.47 | -11.42% |
| S2 | 697.43 | -50.72 | -6.78% |
| S3 | 716.22 | -31.93 | -4.27% |
| S4 | 732.18 | -15.97 | -2.13% |
NEPHROPLUS is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: 736.15 ~ 766.8
Trading Inside opening range
Nephrocare Health Services Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Nephrocare Health Services Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Nephrocare Health Services Ltd stood at 34.2% of traded volume, against a 20-day average of 47.1%.
Nephrocare Health Services announcements: results, concalls, ratings, M&A.
Filings Nephrocare Health Services sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Nephrocare Health Services files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 36 documents below.
Disclosure under SEBI Takeover Regulations
Vikram Vuppala has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial…
Disclosure under SEBI Takeover Regulations
Bessemer Venture Partners Trust has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of…
Agreements
Nephrocare Health Services Limited has informed the Exchange about Agreements
Analysts/Institutional Investor Meet/Con. Call Updates
Nephrocare Health Services Limited has informed the Exchange about Transcript
Analysts/Institutional Investor Meet/Con. Call Updates
Nephrocare Health Services Limited has informed the Exchange about Schedule of meet
Investor decks & rating reports.
Nephrocare Health Services dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Nephrocare Health Services has declared, sequenced by announce and record date.
Nephrocare Health Services corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Nephrocare Health Services Ltd: business, sector, key facts.
What Nephrocare Health Services Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Nephrocare Health Services Ltd is a listed Indian equity, listed as NSE: NEPHROPLUS, BSE: 544647.
Nephrocare Health Services Ltd
Questions investors ask about Nephrocare Health Services Ltd (NEPHROPLUS).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Nephrocare Health Services Ltd (NEPHROPLUS)?
The current share price of Nephrocare Health Services Ltd (NEPHROPLUS) is ₹748.15. Today, the stock has declined by ₹3.15 (0.42%), trading in a range of ₹735 to ₹769.75. The stock opened at ₹759 with a trading volume of 2,04,486 shares.
02Is Nephrocare Health Services Ltd stock a good investment for long-term?
Nephrocare Health Services Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹7,450.3 crores, P/E ratio of 69.60, ROE of 13.40%, and ROCE of 14.10%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Nephrocare Health Services Ltd stock?
The 52-week high price of Nephrocare Health Services Ltd (NEPHROPLUS) is ₹0, while the 52-week low is ₹0. Currently trading at ₹748.15, the stock is Infinity% away from its 52-week low and -Infinity% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Nephrocare Health Services Ltd stock at the current price?
Whether to buy Nephrocare Health Services Ltd stock at ₹748.15 depends on multiple factors. The stock is currently trading with a P/E ratio of 69.60 and P/B ratio of 0.00. Today's performance shows a loss of 0.42%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Nephrocare Health Services Ltd and when is the next dividend?
Nephrocare Health Services Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹748.15, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Nephrocare Health Services Ltd?
Nephrocare Health Services Ltd's key financial metrics include: P/E Ratio: 69.60, P/B Ratio: 0.00, ROE: 13.40%, ROCE: 14.10%, Dividend Yield: 0.00%, EPS: ₹322.00, Book Value: ₹0, and Debt-to-Equity: 0.36. The company's market cap stands at ₹7,450.3 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Nephrocare Health Services Ltd stock performing today in the market?
Nephrocare Health Services Ltd stock opened at ₹759 and is currently trading at ₹748.15, showing a decline of ₹3.15 (0.42%). The intraday high is ₹769.75 and low is ₹735. The trading volume stands at 2,04,486 shares, indicating moderate market participation today.
08What is the P/E ratio of Nephrocare Health Services Ltd and what does it indicate?
Nephrocare Health Services Ltd has a Price-to-Earnings (P/E) ratio of 69.60, which means investors are willing to pay ₹69.60 for every ₹1 of earnings. With an EPS of ₹322.00, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Nephrocare Health Services Ltd (NEPHROPLUS) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B Blackbio DX (3BBLACKBIO) Share PricePeer
- Abbott India (ABBOTINDIA) Share PricePeer
- Acutaas Chemicals (ACUTAAS) Share PricePeer
- AHCL (AHCL) Share PricePeer
- AMANTA (AMANTA) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy